Ms. Bettina Buchholz, United Kingdom
New insights from the SILVER study; a 50 % reduction in calcineurin inhibitors at day 30 achieves a temporary renal-sparing effect but does not impact on long-term renal function after liver transplantation.
Dr. Carmelo Loinaz, Spain
Long term nucleos(t)ide analog therapy after immunglobuline withdrawal in liver transplant recipients to prevent recurrent hepatitis B